IDEXX Laboratories, Inc.
George Fennell (Executive Vice President) reports IDXX insider transactions
AI-generated summary
Executive Vice President George Fennell acquired 1,749 shares of Common Stock in total across three option exercises for $299,747.22 on November 10, 2026. Following these transactions, George Fennell directly held 12,182 shares of Common Stock.
Key facts
- Insider
- George Fennell · Executive Vice President
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | M · exercise or conversion of a derivative | +706 | $141.60 | $99,969.60 | 11,139 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivative | +560 | $178.26 | $99,825.60 | 11,699 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivative | +483 | $206.94 | $99,952.02 | 12,182 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F1 | −706 | $0.00 | $0.00 | 0 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F2 | −560 | $0.00 | $0.00 | 0 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeIncentive Stock Option (right-to-buy)Footnotes F3 | −483 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
- F2 Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023.
- F3 Grant of option to buy 483 shares of Issuer common stock that vests in one installment on February 14, 2024.
More IDXX filings
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 144/A
Filed Nov 5, 2026
- 144
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.